NCT02936180View on ClinicalTrials.gov

Standard Versus High Dose Inactivated Influenza Vaccine in RA

PHASE4CompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

December 31, 2018

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

HD-TIV

BIOLOGICAL

SD-QIV

Trial Locations (1)

H4A 3J1

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

The Arthritis Society, Canada

OTHER

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT02936180 - Standard Versus High Dose Inactivated Influenza Vaccine in RA | Biotech Hunter | Biotech Hunter